semaglutide and optic neuropathy neuritis glp 1 Anterior ischemic in patients treated with semaglutide: report of four cases with a possible association Semaglutide NAION Network Study Announcement

Weight Loss Management GLP-1 Advanced Metabolic slows gastric emptying & promotes satiety, reducing appetite & food intake, which can lead to reduced caloric intake & increased fat burn

These observations are posited to be due to the potential of the peptide to increase growth hormone and subsequently IGF-1, a purported anabolic mediator of growth hormone

Actual packaging, labeling, and pharmacy may vary

For years, we've watched the weight loss industry boom with synthetic options that just didn't align with our holistic approach to wellness

Because it has multiple targets, DPP-4i would be a good choice with which to treat hypertension, especially in patients with chronic inflammatory diseases, such as coronary heart disease, diabetes mellitus, and hyperlipidemia